1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Middle East & Africa Neurorehabilitation Devices Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Middle East & Africa Neurorehabilitation Devices Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Prevalence of Neurological Diseases
- 5.1.2 Growing Number of Clinical Studies on Neurorehabilitation Devices
5.2 Market Opportunities
- 5.2.1 Strategic Initiatives by Market Players
5.3 Future Trends
- 5.3.1 Technological Advancements
5.4 Impact of Drivers and Restraints
6. Middle East & Africa Neurorehabilitation Devices Market Regional Analysis
6.1 Middle East & Africa Neurorehabilitation Devices Market Overview
6.2 Middle East & Africa Neurorehabilitation Devices Market Revenue 2025-2023 (US$ Million)
6.3 Middle East & Africa Neurorehabilitation Devices Market Forecast Analysis
7. Middle East & Africa Neurorehabilitation Devices Market Analysis – by Product Type
7.1 Neurorobotic System
- 7.1.1 Overview
- 7.1.2 Neurorobotic System: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Brain Computer Interface
- 7.2.1 Overview
- 7.2.2 Brain Computer Interface: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Non-invasive Stimulators
- 7.3.1 Overview
- 7.3.2 Non-invasive Stimulators: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Wearable Devices
- 7.4.1 Overview
- 7.4.2 Wearable Devices: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
8. Middle East & Africa Neurorehabilitation Devices Market Analysis – by Application
8.1 Stroke
- 8.1.1 Overview
- 8.1.2 Stroke: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
8.2 Traumatic Brain Injury
- 8.2.1 Overview
- 8.2.2 Traumatic Brain Injury: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
8.3 Spinal Cord Injury
- 8.3.1 Overview
- 8.3.2 Spinal Cord Injury: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
8.4 Parkinson\'s Disease
- 8.4.1 Overview
- 8.4.2 Parkinson\'s Disease: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
8.5 Cerebral Palsy
- 8.5.1 Overview
- 8.5.2 Cerebral Palsy: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
9. Middle East & Africa Neurorehabilitation Devices Market Analysis – by End User
9.1 Rehabilitation Centers
- 9.1.1 Overview
- 9.1.2 Cerebral Palsy: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Cerebral Palsy: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
9.3 Home Care
- 9.3.1 Overview
- 9.3.2 Cerebral Palsy: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
10. Middle East & Africa Neurorehabilitation Devices Market – Middle East & Africa Analysis
10.1 Middle East & Africa
- 10.1.1 Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Key
Country, 2021 and 2023 (%)
- 10.1.1.1 Middle East & Africa Neurorehabilitation Devices Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 Saudi Arabia:
Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
- 10.1.1.1.1 Saudi Arabia: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.1.1.1.2 Saudi Arabia: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Application
- 10.1.1.1.3 Saudi Arabia: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by End User
- 10.1.1.2 the UAE:
Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
- 10.1.1.2.1 the UAE: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.1.1.2.2 the UAE: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Application
- 10.1.1.2.3 the UAE: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by End User
- 10.1.1.3 South Africa:
Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
- 10.1.1.3.1 South Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.1.1.3.2 South Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Application
- 10.1.1.3.3 South Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by End User
- 10.1.1.4 Rest of Middle East & Africa:
Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2023 (US$ Million)
- 10.1.1.4.1 Rest of Middle East & Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Application
- 10.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Middle East & Africa Neurorehabilitation Devices Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 BIONIK
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 BioXtreme Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Blackrock Microsystems Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Ekso Bionics Holdings Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 EMOTIV
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Hocoma AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Medtronic Plc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Renishaw Plc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Tyromotion GmbH
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights